Patents by Inventor Jeremie Decalf

Jeremie Decalf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF USING sIP-10, CD26 INHIBITORS AND CXCR3 LEVELS IN A SAMPLE TO ASSESS CLEARANCE OF INFECTION, RESPONSE TO INTERFERON THERAPY, AND TREATING CHRONIC INFECTIONS
    Publication number: 20120171158
    Abstract: The present invention relates to methods for the treatment of infection, a disease, or a condition using CD26 (DPIV) inhibitors. The present invention also relates to an antibody that binds to the IP-10 protein and a method of monitoring the necessity for administering a CD26 inhibitor to a patient, comprising evaluating a level of sIP-10, a activity of CD26, and/or a level of CXCR3 cells in a sample.
    Type: Application
    Filed: January 20, 2012
    Publication date: July 5, 2012
    Applicant: INSTITUT PASTEUR
    Inventors: Matthew Albert, Armanda Casrouge, Jeremie Decalf, Stanislas Pol, Arnaud Fontanet, Mostafa Mohamed
  • Methods of using sIP-10, CD26 inhibitors and CXCR3 levels in a sample to assess clearance of infection, response to interferon therapy, and treating chronic infections
    Patent number: 8124332
    Abstract: The present invention relates to methods for the treatment of infection, a disease, or a condition using CD26 (DPIV) inhibitors. The present invention also relates to an antibody that binds to the IP-10 protein and a method of monitoring the necessity for administering a CD26 inhibitor to a patient, comprising evaluating a level of sIP-10, a activity of CD26, and/or a level of CXCR3 cells in a sample.
    Type: Grant
    Filed: July 31, 2009
    Date of Patent: February 28, 2012
    Assignee: Institut Pasteur
    Inventors: Matthew Albert, Armanda Casrouge, Jeremie Decalf, Stanislas Pol, Arnaud Fontanet, Mostafa Mohamed
  • Methods of using sIP-10 to assess HCV clearance and/or response to interferon therapy
    Patent number: 7674578
    Abstract: The present invention relates to methods for evaluating and predicting clinical outcomes in patients by measuring levels of sIP-10 protein expression as well as therapies using sIP-10 and its fragments.
    Type: Grant
    Filed: September 14, 2007
    Date of Patent: March 9, 2010
    Assignee: Institut Pasteur
    Inventors: Matthew Albert, Jeremie Decalf, Stanislas Pol, Arnaud Fontanet, Mostafa Mohamed
  • METHODS OF USING sIP-10 TO ASSESS HCV CLEARANCE AND/OR RESPONSE TO INTERFERON THERAPY
    Publication number: 20080119388
    Abstract: The present invention relates to methods for evaluating and predicting clinical outcomes in patients by measuring levels of sIP-10 protein expression as well as therapies using sIP-10 and its fragments.
    Type: Application
    Filed: September 14, 2007
    Publication date: May 22, 2008
    Applicant: INSTITUT PASTEUR
    Inventors: Matthew Albert, Jeremie Decalf, Stanislas Pol, Arnaud Fontanet, Mostafa Mohamed